FEEDBACK MEDICAL LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  -25.4%

  £1,180,522 → £880,221

• Cash

  +1,207.6%

  £9,457 → £123,661

• Net assets

  -1,132.8%

  £579,023 → -£5,980,318

• Employees

  +3.8%

  26 → 27

• Operating profit

  -10.9%

  -£3,012,492 → -£3,339,802

• Profit before tax

  -118.5%

  -£3,012,492 → -£6,583,173

• Wages

  +6.3%

  £1,569,275 → £1,667,866

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

1. FEEDBACK MEDICAL LIMITED 2018-04-11 → present
2. CAMBRIDGE COMPUTED IMAGING LIMITED 2000-09-14 → 2018-04-11
3. M&R 774 LIMITED 2000-07-03 → 2000-09-14

Accounting basis

IFRS

Reporting scope

Standalone (parent only)

Auditor

Price Bailey LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“The Directors have a reasonable expectation that the Company has adequate resources both from its operations and from the continued support of its parent company Feedback plc which has undertaken to continue to provide financial support to the Company for at least the next twelve months from the date of approval of the financial statements.”

Group structure

1. FEEDBACK MEDICAL LIMITED · parent
   1. TexRAD Limited 9% · United Kingdom
   2. Feedback Medical India PVT Ltd 99.9% · India

Significant events

• “An impairment review for the cash generating unit (CGU) - Bleepa has been performed based on its VIU. Bleepa belongs to the Company reportable segment. Management prepared five-year cash flow forecasts (aligned with the useful life of the intangible assets) under several scenarios reflecting a range of potential outcomes. To ensure a prudent assessment the most conservative scenario was selected as the basis for the impairment review, whereby revenues are generated from existing customer contracts only over this five-year period and without any terminal value. The cashflows were discounted resulting in an NPV-derived equity value of £572,087 in this conservative scenario. The primary events and circumstances that led to the recognition of an impairment loss were: Fall in the share price of parent company Feedback plc; Uncertainty around NHS contracts and the timing of those contracts due to the ongoing merging of NHSE with the DHSC and the requirement for ICBs to reduce operational costs; Wider macro-economic environment of the UK having an effect on growth rates.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

6

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.